Oxford Cannabinoid Technologies: Funding & Investors (Sep 2026)
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.
Oxford Cannabinoid Technologies has raised $720k across 1 funding round on record, the most recent an undisclosed round of $720k announced in Feb 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oxford Cannabinoid Technologies Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Oxford Cannabinoid Technologies Funding Rounds
Oxford Cannabinoid Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Oxford Cannabinoid Technologies Funding Compared to Other Biotechnology Startups
Oxford Cannabinoid Technologies' latest round of $720k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oxford Cannabinoid Technologies in Biotechnology and Oxford
Companies Similar to Oxford Cannabinoid Technologies
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Oxford Cannabinoid Technologies Funding FAQs
What does Oxford Cannabinoid Technologies do?
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.
How much funding has Oxford Cannabinoid Technologies raised?
Oxford Cannabinoid Technologies has raised $720k across 1 round on record. The most recent is an undisclosed round of $720k announced in Feb 2024.
When did Oxford Cannabinoid Technologies last raise funding?
Oxford Cannabinoid Technologies' most recent funding round on record is an undisclosed round of $720k, announced in Feb 2024.
Who founded Oxford Cannabinoid Technologies?
FundedIQ lists Tarek Tabsh (Founder) at Oxford Cannabinoid Technologies.
Where is Oxford Cannabinoid Technologies headquartered?
Oxford Cannabinoid Technologies is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Oxford Cannabinoid Technologies have?
Oxford Cannabinoid Technologies is in the 11-50 employee band.
How does Oxford Cannabinoid Technologies' funding compare to other Biotechnology startups?
Oxford Cannabinoid Technologies' latest round of $720k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Oxford Cannabinoid Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oxford Cannabinoid Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.